Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2013
Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial
Z F Jiang, M Cristofanilli, Z M Shao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
July 31, 2019
[Current trends of breast reconstruction after mastectomy in China: a cross-sectional study]
B Q Xiu, R Guo, B L Yang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
August 20, 2019
[Current practice of implant-based breast reconstruction: results from China national practice questionnaire survey]
R Guo, B Q Xiu, Y H Su, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
October 28, 2016
[Incidental internal mammary lymph node biopsy in 113 cases of breast cancer undergoingfree abdominal flap breast reconstruction and its influencing factors]
C L Quan, N S Huang, B L Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 1, 2020
[Current trend of breast cancer neoadjuvant treatment in China: a cross-sectional study]
J Wang, B Q Xiu, R Guo, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
January 3, 2018
[Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai]
F Wu, M Mo, X X Qin, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2012
PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy
Y Z Chen, J Y Xue, C M Chen, et al.
Technology in Cancer Research & Treatment
|
September 15, 2012
Delineation of the cardiac substructures based on PET-CT and contrast-enhanced CT in patients with left breast cancer treated with postoperative radiotherapy
X-L Yu, Q Zhang, J-Y Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2018
Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer
J Zhang, Y Lin, X J Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2025
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
J J Li, Z H Wang, L Chen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2013
Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial
Z F Jiang, M Cristofanilli, Z M Shao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
July 31, 2019
[Current trends of breast reconstruction after mastectomy in China: a cross-sectional study]
B Q Xiu, R Guo, B L Yang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
August 20, 2019
[Current practice of implant-based breast reconstruction: results from China national practice questionnaire survey]
R Guo, B Q Xiu, Y H Su, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
October 28, 2016
[Incidental internal mammary lymph node biopsy in 113 cases of breast cancer undergoingfree abdominal flap breast reconstruction and its influencing factors]
C L Quan, N S Huang, B L Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 1, 2020
[Current trend of breast cancer neoadjuvant treatment in China: a cross-sectional study]
J Wang, B Q Xiu, R Guo, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
January 3, 2018
[Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai]
F Wu, M Mo, X X Qin, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2012
PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy
Y Z Chen, J Y Xue, C M Chen, et al.
Technology in Cancer Research & Treatment
|
September 15, 2012
Delineation of the cardiac substructures based on PET-CT and contrast-enhanced CT in patients with left breast cancer treated with postoperative radiotherapy
X-L Yu, Q Zhang, J-Y Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2018
Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer
J Zhang, Y Lin, X J Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2025
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
J J Li, Z H Wang, L Chen, et al.
Page
of 10